{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Moura LM"],"funding":["NICHD NIH HHS","NCI NIH HHS"],"pagination":["685-694"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC5117903"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["8"],"pubmed_abstract":["<h4>Objective</h4>Many effective medical therapies are available for treating neurological diseases, but these therapies tend to be expensive and adherence is critical to their effectiveness. We used patient-reported data to examine the frequency and determinants of financial barriers to medication adherence among individuals treated for neurological disorders.<h4>Patients and methods</h4>Patients completed cross-sectional surveys on iPads as part of routine outpatient care in a neurology clinic. Survey responses from a 3-month period were collected and merged with administrative sources of demographic and clinical information (eg, insurance type). We explored the association between patient characteristics and patient-reported failure to refill prescription medication due to cost in the previous 12 months, termed here as \"nonadherence\".<h4>Results</h4>The population studied comprised 6075 adults who were presented between July and September 2015 for outpatient neurology appointments. The mean age of participants was 56 (standard deviation: 18) years, and 1613 (54%) were females. The patients who participated in the surveys (2992, 49%) were comparable to nonparticipants with respect to gender and ethnicity but more often identified English as their preferred language (94% vs 6%, <i>p</i><0.01). Among respondents, 9.8% (n=265) reported nonadherence that varied by condition. These patients were more frequently Hispanic (16.7% vs 9.8% white, <i>p</i>=0.01), living alone (13.9% vs 8.9% cohabitating, <i>p</i><0.01), and preferred a language other than English (15.3% vs 9.4%, <i>p</i>=0.02).<h4>Conclusion</h4>Overall, the magnitude of financial barriers to medication adherence appears to vary across neurological conditions and demographic characteristics."],"journal":["ClinicoEconomics and outcomes research : CEOR"],"pubmed_title":["Patient-reported financial barriers to adherence to treatment in neurology."],"pmcid":["PMC5117903"],"funding_grant_id":["R01 HD075121","R01 CA164023"],"pubmed_authors":["Schwamm LH","Moura LM","Seitz MP","Hsu J","Schwamm EL","Moura Junior V","Hoch DB"],"additional_accession":[]},"is_claimable":false,"name":"Patient-reported financial barriers to adherence to treatment in neurology.","description":"<h4>Objective</h4>Many effective medical therapies are available for treating neurological diseases, but these therapies tend to be expensive and adherence is critical to their effectiveness. We used patient-reported data to examine the frequency and determinants of financial barriers to medication adherence among individuals treated for neurological disorders.<h4>Patients and methods</h4>Patients completed cross-sectional surveys on iPads as part of routine outpatient care in a neurology clinic. Survey responses from a 3-month period were collected and merged with administrative sources of demographic and clinical information (eg, insurance type). We explored the association between patient characteristics and patient-reported failure to refill prescription medication due to cost in the previous 12 months, termed here as \"nonadherence\".<h4>Results</h4>The population studied comprised 6075 adults who were presented between July and September 2015 for outpatient neurology appointments. The mean age of participants was 56 (standard deviation: 18) years, and 1613 (54%) were females. The patients who participated in the surveys (2992, 49%) were comparable to nonparticipants with respect to gender and ethnicity but more often identified English as their preferred language (94% vs 6%, <i>p</i><0.01). Among respondents, 9.8% (n=265) reported nonadherence that varied by condition. These patients were more frequently Hispanic (16.7% vs 9.8% white, <i>p</i>=0.01), living alone (13.9% vs 8.9% cohabitating, <i>p</i><0.01), and preferred a language other than English (15.3% vs 9.4%, <i>p</i>=0.02).<h4>Conclusion</h4>Overall, the magnitude of financial barriers to medication adherence appears to vary across neurological conditions and demographic characteristics.","dates":{"release":"2016-01-01T00:00:00Z","publication":"2016","modification":"2025-04-04T09:21:01.841Z","creation":"2019-03-27T02:29:27Z"},"accession":"S-EPMC5117903","cross_references":{"pubmed":["27895506"],"doi":["10.2147/CEOR.S119971"]}}